CAM2029 represents a significant advance replacing cumbersome deep muscle injections with a user-friendly pen device similar to modern insulin and GLP-1 delivery systems. The practical benefits are remarkable: monthly administration, storage at room temperature, and no more traveling with cooling equipment. These improvements may seem incremental to outsiders, but for patients managing acromegaly, they represent important quality-of-life enhancements. But I'll let Fredrik and the Camurus team tell you all about it in this podcast.

I met Dr. Tiberg at his new offices, toured the lab, and had a fantastic chat about the new drugs and the challenges and opportunities for people with rare diseases, and, importantly, for those working to make their lives a little bit better. I hope you enjoy listening to it as much as I did producing it.